Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility

Oncogene volume 22, pages 5045–5054 (2003)Cite this article

Abstract

The AP-1 transcription factor is composed of members of the Fos, Jun and ATF families, and plays a key role in tumor progression. We investigated whether Fos proteins regulate cell motility, and if so, whether this capacity is related to their transactivation potential. Two cell lines with different expression profiles of AP-1 were employed focusing on the Fos-family members c-Fos, Fra-1 and Fra-2. Transactivation motifs are found in c-Fos, but not in Fra-1 or Fra-2. The adenocarcinoma CSML0 cells display a low motility and do not express Fra-1 or Fra-2, and only very little c-Fos. In contrast, the fibroblastoid L929 cells express both Fra-1 and Fra-2, but no c-Fos, and these cells display a high motility. Transfection with Fra-1 or c-Fos, but not with Fra-2, strongly enhanced the motility of CSML0 cells. The effect of Fra-1 required the presence of the N-terminal domain of this protein. Conversely, transfection with a Fos dominant-negative mutant or with anti-sense fra-1 or fra-2, strongly reduced the motility of L929 cells. Changes in cell motility correlated with the morphological appearance and the degree of contact with the substratum. We conclude that Fos proteins have distinct roles in the regulation of cell motility.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Albrektsen T and Fleckner J . (2001). Mol Pharmacol., 59, 567–575.

  • Andersen H, Mahmood S, Tkach V, Cohn M, Kustikova O, Grigorian M, Berezin V, Bock E, Lukanidin E and Tulchinsky E . (2002). Oncogene, 21, 4843–4848.

  • Bergers G, Graninger P, Braselmann S, Wrighton C and Busslinger M . (1995). Mol. Cell. Biol., 15, 3748–3758.

  • Dunn GA . (1983). Leucocyte Locomotion and Chemotaxis, Keller H, Till GO and Abor A (eds.) Birkhauser Verlag: Basel, pp. 14–33.

    Book  Google Scholar 

  • DiMilla PA, Stone JA, Quinn JA, Albelda SM and Lauffenburger DA . (1993). J. Cell. Biol., 122, 729–737.

  • Funk M, Poensgen B, Graulich W, Jerome V and Müller R . (1997). Mol. Cell. Bio., 17, 537–544.

  • Hai T and Curran T . (1991). Proc. Natl. Acad. Sci. USA, 88, 3720–3724.

  • Hirai SI, Ryseck RP, Mechta F, Bravo R and Yaniv M . (1989). EMBO J., 8, 1433–1439.

  • Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T and Rao A . (1993). Nature, 365, 352–355.

  • Kassis J, Lauffenburger DA, Turner T and Wells A . (2001). Semin. Cancer Biol., 11, 105–117.

  • Kataoka K, Fujiwara KT, Noda M and Nishizawa M . (1994). Mol. Cell. Biol., 14, 7581–7591.

  • Kovary K and Bravo R . (1992). Mol. Cell. Biol., 12, 5051–5023.

  • Kustikova O, Kramerov D, Grigorian M, Berezin V, Bock E, Lukanidin E and Tulchinsky E . (1998). Mol. Cell. Biol., 18, 7095–7105.

  • Lauffenburger DA and Lindermann JJ . (1993). Receptors, Models for Binding, Trafficking and Signaling. Oxford University Press: New York, pp. 236–344.

    Google Scholar 

  • Lee HY, Chaudhary J, Walsh G, Hong W and Kurie J . (1998). Oncogene, 16, 3039–3046.

  • Lee W, Mitchell P and Tjian R . (1987). Cell, 49, 741–752.

  • Lepekhin EA, Walmod PS, Berezin A, Berezin V and Bock E . (2000). Methods Mol. Biol., 161, 85–100.

  • Malliri A, Symons M, Hennigan RF, Hurlstone AFL, Lamb RF, Wheeler T and Ozanne BW . (1998). J. Cell Biol., 143, 1087–1099.

  • Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ and Wagner EF . (2000). Nat. Genet., 24, 184–187.

  • Mechta F, Lallemand D, Pfarr C and Yaniv M . (1997). Oncogene, 14, 837–847.

  • Murakami M, Sonobe M, Ui M, Kabuyama Y, Watanabe H, Wada T, Handa H and Iba H . (1997). Oncogene, 14, 2435–2444.

  • Olive M, Krylov D, Echlin DR, Gardner K, Taparowsky E and Vinson C . (1997). J. Biol. Chem., 272, 18586–18594.

  • Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA and Horwitz AF . (1997). Nature, 385, 537–540.

  • Senin VM, Ivanov AM, Afanasjeva AV and Buntsevich AM . (1984). Vestn USSR Acad. Med. Sci., 5, 85–91.

  • Suzuki T, Okuno H, Yoshido T, Endo T, Nishina H and Iba H . (1991). Nucl. Acids Res., 19, 5537–5542.

  • Tulchinsky E . (2000). Histol. Histopath., 15, 921–928.

  • Walmod PS, Foley A, Berezin A, Ellerbeck U, Nau H, Bock E and Berezin V . (1998). Cell Motil. Cytoskeleton, 40, 220–237.

  • Walmod PS, Hartmann-Petersen R, Berezin A, Prag S, Kiselyov VV, Berezin V and Bock E . (2000). Methods Mol. Biol., 161, 59–83.

  • Wisdom R and Verma IM . (1993). Mol. Cell. Biol., 13, 7429–7438.

Download references

Acknowledgements

This work was supported by grants from the Danish Cancer Society, the Danish Medical Research Council, the Danish Cancer Research Foundation, the Danish Natural Science Research Council, The John and Birthe Meyer Foundation and the Lundbeck Foundation.

Author information

Author notes

  1. Eugene Tulchinsky

    Present address: University of Leicester, Division of Urology, Clinical Sciences Unit, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, UK

Authors and Affiliations

  1. Protein Laboratory, Institute of Molecular Pathology, School of Medicine, Copenhagen University, Copenhagen, DK-2200, Denmark

    Vadim Tkach, Elisabeth Bock & Vladimir Berezin

  2. Department of Molecular Cancer Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen Ø, DK-2100, Denmark

    Eugene Tulchinsky & Eugene Lukanidin

  3. Laboratory of Metabolism, NCI, National Institutes of Health, Bethesda, 20892, MD, USA

    Charles Vinson

Authors
  1. Vadim Tkach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eugene Tulchinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eugene Lukanidin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charles Vinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elisabeth Bock
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vladimir Berezin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vladimir Berezin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tkach, V., Tulchinsky, E., Lukanidin, E. et al. Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility. Oncogene 22, 5045–5054 (2003). https://doi.org/10.1038/sj.onc.1206570

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206570

Keywords

This article is cited by

Search

Advanced search

Quick links